Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2225 of 3173 entries
View as:

Zmax Compared to Augmentin in Sinusitis

Phase: N/A Priority: Normal
NCT ID: NCT00367120 Org: User:
Start: 06/30/06 End: 02/28/07 Due: 02/28/08

Safety, Tolerability And On-Body Temperature Of A Disposable Heatwrap Device For The Lower Back

Phase: N/A Priority: Normal
NCT ID: NCT01055262 Org: User:
Start: 01/31/10 End: 02/28/10 Due: 02/28/11

Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)

Phase: N/A Priority: Normal
NCT ID: NCT00894686 Org: User:
Start: 04/26/09 End: 05/10/17 Due: 05/10/18

A Study to Learn About How Safe and Effective is 20vPnC and 13vPnC Vaccines in Chinese Adults

Phase: N/A Priority: Normal
NCT ID: NCT07019909 Org: User:
Start: 07/14/25 End: 03/10/26 Due: 03/10/27

Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

Phase: N/A Priority: Normal
NCT ID: NCT04321031 Org: User:
Start: 06/15/20 End: 02/21/24 Due: 02/21/25

A Study to Learn About Study Medicine Called PF-07261271 in Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT05536440 Org: User:
Start: 10/17/22 End: 02/29/24 Due: 02/28/25

Study to Evaluate Safety and Tolerability of a Single Dose of PF-06741086 in Chinese Adult Participants With Severe Hemophilia

Phase: N/A Priority: Normal
NCT ID: NCT04878731 Org: User:
Start: 04/16/21 End: 08/10/21 Due: 08/10/22

Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00282048 Org: User:
Start: 03/31/06 End: 06/30/09 Due: 06/30/10

Tygacil Drug Use Investigation

Phase: N/A Priority: Normal
NCT ID: NCT01789905 Org: User:
Start: 04/15/13 End: 06/16/17 Due: 06/16/18

Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)

Phase: N/A Priority: Normal
NCT ID: NCT02100228 Org: User:
Start: 07/14/14 End: 02/08/17 Due: 02/08/18

Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease

Phase: N/A Priority: Normal
NCT ID: NCT00962260 Org: User:
Start: - End: - Due: -

Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00004252 Org: User:
Start: 11/30/99 End: 09/30/07 Due: 09/30/08

Effect Of A Treatment Optimization Program To Improve Satisfaction With Viagra

Phase: N/A Priority: Normal
NCT ID: NCT00159848 Org: User:
Start: 09/30/03 End: 09/30/03 Due: 09/30/04

Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00735904 Org: User:
Start: 12/31/08 End: 11/30/11 Due: 11/30/12

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)

Phase: N/A Priority: Normal
NCT ID: NCT00658762 Org: User:
Start: 05/31/08 End: 04/30/09 Due: 04/30/10

A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00219622 Org: User:
Start: 05/31/04 End: 07/31/05 Due: 07/31/06

A Phase 1/2A, Single Dose Study Of PF-04383119 In Japanese Patients With Moderate To Severe Pain From Osteoarthritis Of The Knee

Phase: N/A Priority: Normal
NCT ID: NCT00669409 Org: User:
Start: 06/06/08 End: 12/25/09 Due: 12/25/10

To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

Phase: N/A Priority: Normal
NCT ID: NCT00141414 Org: User:
Start: 11/30/97 End: 10/31/05 Due: 10/31/06

Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.

Phase: N/A Priority: Normal
NCT ID: NCT00561951 Org: User:
Start: 11/30/07 End: 01/31/09 Due: 01/31/10

A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022

Phase: N/A Priority: Normal
NCT ID: NCT01254656 Org: User:
Start: 02/28/11 End: 04/30/13 Due: 04/30/14

Defining Remission With Etanercept in AS in Real Life Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT02202850 Org: User:
Start: 08/12/14 End: 04/26/17 Due: 04/26/18

Macugen Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT00735943 Org: User:
Start: 11/30/08 End: 08/31/10 Due: 08/31/11

Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of PF-06730512

Phase: N/A Priority: Normal
NCT ID: NCT03146065 Org: User:
Start: 05/10/17 End: 05/03/18 Due: 05/03/19

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00959946 Org: User:
Start: 09/30/09 End: 03/31/11 Due: 03/31/12

Phase 1, Single and Multiple Doses Study of Sitaxentan in Japanese and Western Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00981968 Org: User:
Start: 09/30/09 End: 11/30/09 Due: 11/30/10